Oncomine tumor-specific panels

Focused cancer research

A one-size-fits-all approach just doesn’t work for everyone, so we’ve developed a range of Oncomine assays to cover the spectrum of panel sizes and purposes.

Choose Oncomine tumor-specific panels

Ion Torrent Oncomine tumor-specific panels complement Oncomine assays, providing end-to-end solutions for researching the molecular profile of specific tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples.

These dynamic panels are created from a curated inventory of pre-tested genes relevant to cancer research and sized to be economical (15–30 genes).

  • Available via ampliseq.com and manufactured on demand
  • Low sample input requirement and robust performance on FFPE tissue
  • End-to-end research workflow, including bioinformatics and a reporting solution
  • Specialized support to enable rapid implementation of panels in your lab

Oncomine tumor-specific panels for cancer research 

Oncomine Bladder Panel

25-gene panel applicable to urothelial carcinoma (~90% of bladder cancers). Contains genes such as PIK3CA, FGFR3, and ERBB2.

Oncomine Kidney Panel

15-gene panel applicable to renal cell carcinomas (the majority of kidney cancers). Contains genes such as VHL, MTOR, and PBRM1

Oncomine BRCA Expanded Panel

15-gene panel containing BRCA1 and BRCA2 as well as HR pathway genes important for ovarian, breast, and prostate cancer research. Contains genes such as ATM, PALB2, and BRIP1.

Oncomine Liver Panel

22-gene panel applicable to hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Contains genes such as TP53, MYC, TERT, and CTNNB1.

Oncomine Colorectal and Pancreatic Panel

24-gene panel applicable to colorectal and pancreatic adenocarcinoma, including DNA mismatch repair pathway genes. Also contains genes such as APC, KRAS, and NRAS.

Oncomine Lymphoma Panel

25-gene panel applicable to non-Hodgkin’s lymphomas (primarily diffuse large B cell (DLBCL)) as well as to Hodgkin’s lymphoma. Contains genes such as BCL2, MYD88, and CARD11.

Oncomine Gastric and Esophageal Panel

17-gene panel applicable to gastric, esophageal, and gastroesophageal adenocarcinoma. Contains genes such as TP53, ERBB2, and CDKN2A.

Oncomine Melanoma Panel

29-gene panel applicable to cutaneous and uveal melanoma. Contains genes such as BRAF, NRAS, and CDKN2A.

Oncomine Gynecological Panel

19-gene panel applicable to endometrial, cervical, and ovarian carcinomas. Contains genes such as PTEN, BRCA2, and CTNNB1.

Oncomine Prostate Panel

21-gene panel applicable to prostate adenocarcinoma. Contains genes such as AR, PTEN, and MYC.

Oncomine Tumor Specific RNA Panel

49-gene research panel complements the Oncomine tumor specific panels; however, it is not available with the Oncomine Lymphoma Panel. This RNA-only panel uses FusionSync technology to detect known, novel, and rare fusions from even small sample inputs. This panel cannot be customized.

Oncomine HRR Pathway Predesigned Panel

28-gene panel containing homologous recombination repair (HRR) pathway genes. Inclusive of genes found on the Oncomine BRCA Expanded Panel plus additional non-HRR genes such as KRAS and PIK3CA important for ovarian, breast, prostate, and pancreatic cancer research.*

*The HRR Pathway Predesigned Panel does not come with a preconfigured Ion Reporter analysis workflow.